Tuberculosis (TB) has remained at the forefront of the global infectious disease burden for
centuries. Concerted global efforts to eliminate TB have been hindered by the complexity of …

Drug repurposing, also known as drug repositioning, entails the application of pre-approved
or formerly assessed drugs having potentially functional therapeutic amalgams for curing …

Tuberculosis, caused by Mycobacterium tuberculosis, remains a major public health
concern, demanding new antibiotics with innovative therapeutic principles due to the …

Tuberculosis (TB) is still a worldwide public health burden, as more than 1.3 million deaths
are expected to be reported in 2021. Even though almost 20 million patients have completed …

Ever increasing drug resistance has become an impeding threat that continues to hamper
effective tackling of otherwise treatable tuberculosis (TB). Such dismal situation necessitates …

Background Patients with tuberculosis (TB) often harbor diverse bacteria in their sputum,
including both commensal and opportunistic pathogens. This study aimed to characterize …

Drug-resistant tuberculosis (DR-TB) has continued to be a global health cataclysm. It is an
arduous condition to tackle but is curable with the proper choice of drug and adherence to …

Ethnopharmacological relevance Although the available medicines can cure almost all
tuberculosis drug-susceptible patients some problems including the emergence of multi …

The quinoline moiety remains a privileged antitubercular (anti‐TB) pharmacophore,
whereas 8‐nitrobenzothiazinones are emerging potent antimycobacterial agents with two …

People from low-income countries are increasingly affected by neglected communicable
diseases, and the health care system frequently overlooks their needs. Currently, these …